HomeInsightsStock Comparison

Beta Drugs Ltd vs Kobo Biotech Ltd Stock Comparison

Beta Drugs Ltd vs Kobo Biotech Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Beta Drugs Ltd is ₹ 1675 as of 22 Jul 11:59.
  • The P/E Ratio of Beta Drugs Ltd changed from 4.1 on March 2020 to 32.5 on March 2024 . This represents a CAGR of 51.29% over 5 yearsThe P/E Ratio of Kobo Biotech Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Beta Drugs Ltd changed from ₹ 38.46 crore on March 2020 to ₹ 1186 crore on March 2024 . This represents a CAGR of 98.53% over 5 yearsThe Market Cap of Kobo Biotech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Beta Drugs Ltd for the Jun '24 is ₹ 0 crore as compare to the Mar '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Kobo Biotech Ltd for the Jun '24 is ₹ 0.02 crore as compare to the Mar '24 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16%.
  • The ebitda of Beta Drugs Ltd for the Jun '24 is ₹ 0 crore as compare to the Mar '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Kobo Biotech Ltd for the Jun '24 is ₹ -0.32 crore as compare to the Mar '24 ebitda of ₹ -0.25 crore. This represent the growth of 28%.
  • The net profit of Beta Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The net profit of Kobo Biotech Ltd changed from ₹ -1.23 crore to ₹ -1.33 crore over 5 quarters. This represents a CAGR of 6.45% .
  • The Dividend Payout of Beta Drugs Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kobo Biotech Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Beta Drugs Ltd

  • Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
  • Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
  • Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
  • The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
  • The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

About Kobo Biotech Ltd

  • Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
  • Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
  • The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.

Beta Drugs Ltd News Hub

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 15 May 2025. Po...

Read more

10 May 2025 10:59

News

Beta Drugs announces board meeting date

Beta Drugs will hold a meeting of the Board of Directors of the Company on 27 March 2025. ...

Read more

20 Mar 2025 14:34

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 5 February 2025...

Read more

03 Feb 2025 10:49

News

Beta Drugs schedules EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

28 Nov 2024 15:41

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024...

Read more

04 Nov 2024 14:01

News

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

21 Oct 2024 13:59

Kobo Biotech Ltd News Hub

News

Kobo Biotech to discuss results

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 14 August 202...

Read more

13 Aug 2024 10:21

News

Kobo Biotech to convene board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 30 May 2024 P...

Read more

28 May 2024 15:31

News

Kobo Biotech to conduct board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2...

Read more

09 Feb 2024 14:57

News

Kobo Biotech to hold board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 10 November 2...

Read more

03 Nov 2023 17:17

News

Kobo Biotech to hold AGM

Kobo Biotech announced that the 30th Annual General Meeting (AGM) of the company will be h...

Read more

09 Sep 2023 18:44

News

Kobo Biotech to declare Quarterly Result

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 11 August 202...

Read more

07 Aug 2023 13:02

SWOT Analysis Of Beta Drugs Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Kobo Biotech Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Beta Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Kobo Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Beta Drugs Ltd and Kobo Biotech Ltd

Which company has a larger market capitalization, Beta Drugs Ltd or Kobo Biotech Ltd?

Market cap of Beta Drugs Ltd is 1,693 Cr while Market cap of Kobo Biotech Ltd is 6 Cr

What are the key factors driving the stock performance of Beta Drugs Ltd and Kobo Biotech Ltd?

The stock performance of Beta Drugs Ltd and Kobo Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beta Drugs Ltd and Kobo Biotech Ltd?

As of July 22, 2025, the Beta Drugs Ltd stock price is INR ₹1677.65. On the other hand, Kobo Biotech Ltd stock price is INR ₹2.53.

How do dividend payouts of Beta Drugs Ltd and Kobo Biotech Ltd compare?

To compare the dividend payouts of Beta Drugs Ltd and Kobo Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions